Personalis to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Rhea-AI Summary

Personalis, Inc. (Nasdaq: PSNL) announced its participation in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference scheduled for February 18, 2021, at 12:00 p.m. ET. As a leader in cancer genomics and population sequencing, Personalis provides comprehensive molecular data about cancer and immune responses. The company also supports the U.S. Department of Veterans Affairs Million Veterans Program and offers the innovative ImmunoID NeXT Platform to aid biopharmaceutical customers in understanding genetic and immune system data from single samples.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021 at 12:00 p.m. Eastern Time.

About Personalis, Inc.

Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing programs globally and is currently the sole sequencing provider to the U.S. Department of Veterans Affairs Million Veterans Program. In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis^® ImmunoID NeXT Platform^® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue or blood sample. The Personalis^® Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210204005143/en/

FAQ

When will Personalis, Inc. (PSNL) present at the BTIG conference?

Personalis, Inc. will present at the BTIG Virtual MedTech Conference on February 18, 2021, at 12:00 p.m. Eastern Time.

What does Personalis, Inc. (PSNL) specialize in?

Personalis, Inc. specializes in advanced genomics for cancer, focusing on population sequencing and providing comprehensive data on cancer and immune responses.

What is the ImmunoID NeXT Platform from Personalis, Inc.?

The ImmunoID NeXT Platform is designed to provide extensive genetic and immune data from a single tissue or blood sample, aiding in the development of next-generation cancer therapies.

Who is the primary client for Personalis' sequencing services?

Personalis is the sole sequencing provider for the U.S. Department of Veterans Affairs Million Veterans Program.